Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults
Twelve adults-seven with nephrotic syndrome due to proliferative glomerulonephritis and five with persistent proliferative glomerulonephritis-were given prednisolone alone, or in combination with azathioprine or with azathioprine and cyclophosphamide. Prednisolone alone or with azathioprine did not...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Published: |
Elsevier
1971
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/25809/ https://doi.org/10.1016/S0140-6736(71)92365-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.25809 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.258092021-03-30T04:28:11Z http://eprints.um.edu.my/25809/ Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults Mukherjee, A.P. R Medicine Twelve adults-seven with nephrotic syndrome due to proliferative glomerulonephritis and five with persistent proliferative glomerulonephritis-were given prednisolone alone, or in combination with azathioprine or with azathioprine and cyclophosphamide. Prednisolone alone or with azathioprine did not produce remission but on the combined prednisolone/azathioprine/cyclophosphamide treatment ten patients recovered completely. No serious toxic reactions to this regimen were ob served. Triple-drug therapy seems to interfere with the immune process more effectively than double therapy. © 1971. Elsevier 1971 Article PeerReviewed Mukherjee, A.P. (1971) Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults. The Lancet, 298 (7738). pp. 1350-1353. ISSN 0140-6736 https://doi.org/10.1016/S0140-6736(71)92365-8 doi:10.1016/S0140-6736(71)92365-8 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
R Medicine |
spellingShingle |
R Medicine Mukherjee, A.P. Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
description |
Twelve adults-seven with nephrotic syndrome due to proliferative glomerulonephritis and five with persistent proliferative glomerulonephritis-were given prednisolone alone, or in combination with azathioprine or with azathioprine and cyclophosphamide. Prednisolone alone or with azathioprine did not produce remission but on the combined prednisolone/azathioprine/cyclophosphamide treatment ten patients recovered completely. No serious toxic reactions to this regimen were ob served. Triple-drug therapy seems to interfere with the immune process more effectively than double therapy. © 1971. |
format |
Article |
author |
Mukherjee, A.P. |
author_facet |
Mukherjee, A.P. |
author_sort |
Mukherjee, A.P. |
title |
Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
title_short |
Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
title_full |
Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
title_fullStr |
Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
title_full_unstemmed |
Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
title_sort |
combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults |
publisher |
Elsevier |
publishDate |
1971 |
url |
http://eprints.um.edu.my/25809/ https://doi.org/10.1016/S0140-6736(71)92365-8 |
_version_ |
1696976585612066816 |
score |
13.211869 |